These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 9124802)

  • 1. Machado-Joseph disease gene product is a cytoplasmic protein widely expressed in brain.
    Paulson HL; Das SS; Crino PB; Perez MK; Patel SC; Gotsdiner D; Fischbeck KH; Pittman RN
    Ann Neurol; 1997 Apr; 41(4):453-62. PubMed ID: 9124802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Machado-Joseph disease gene product identified in lymphocytes and brain.
    Wang G; Ide K; Nukina N; Goto J; Ichikawa Y; Uchida K; Sakamoto T; Kanazawa I
    Biochem Biophys Res Commun; 1997 Apr; 233(2):476-9. PubMed ID: 9144561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Caffeine and adenosine A(2A) receptor inactivation decrease striatal neuropathology in a lentiviral-based model of Machado-Joseph disease.
    Gonçalves N; Simões AT; Cunha RA; de Almeida LP
    Ann Neurol; 2013 May; 73(5):655-66. PubMed ID: 23625556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of Onuf's nucleus in Machado-Joseph disease: a morphometric and immunohistochemical study.
    Shimizu H; Yamada M; Toyoshima Y; Ikeuchi T; Onodera O; Takahashi H
    Acta Neuropathol; 2010 Oct; 120(4):439-48. PubMed ID: 20503052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A mutant ataxin-3 putative-cleavage fragment in brains of Machado-Joseph disease patients and transgenic mice is cytotoxic above a critical concentration.
    Goti D; Katzen SM; Mez J; Kurtis N; Kiluk J; Ben-Haïem L; Jenkins NA; Copeland NG; Kakizuka A; Sharp AH; Ross CA; Mouton PR; Colomer V
    J Neurosci; 2004 Nov; 24(45):10266-79. PubMed ID: 15537899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterogeneous intracellular localization and expression of ataxin-3.
    Trottier Y; Cancel G; An-Gourfinkel I; Lutz Y; Weber C; Brice A; Hirsch E; Mandel JL
    Neurobiol Dis; 1998 Nov; 5(5):335-47. PubMed ID: 10069576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Striatal and nigral pathology in a lentiviral rat model of Machado-Joseph disease.
    Alves S; Régulier E; Nascimento-Ferreira I; Hassig R; Dufour N; Koeppen A; Carvalho AL; Simões S; de Lima MC; Brouillet E; Gould VC; Déglon N; de Almeida LP
    Hum Mol Genet; 2008 Jul; 17(14):2071-83. PubMed ID: 18385100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Motor uncoordination and neuropathology in a transgenic mouse model of Machado-Joseph disease lacking intranuclear inclusions and ataxin-3 cleavage products.
    Silva-Fernandes A; Costa Mdo C; Duarte-Silva S; Oliveira P; Botelho CM; Martins L; Mariz JA; Ferreira T; Ribeiro F; Correia-Neves M; Costa C; Maciel P
    Neurobiol Dis; 2010 Oct; 40(1):163-76. PubMed ID: 20510362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Full-length expanded ataxin-3 enhances mitochondrial-mediated cell death and decreases Bcl-2 expression in human neuroblastoma cells.
    Tsai HF; Tsai HJ; Hsieh M
    Biochem Biophys Res Commun; 2004 Nov; 324(4):1274-82. PubMed ID: 15504352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regional and cellular expression of the Machado-Joseph disease gene in brains of normal and affected individuals.
    Nishiyama K; Murayama S; Goto J; Watanabe M; Hashida H; Katayama S; Nomura Y; Nakamura S; Kanazawa I
    Ann Neurol; 1996 Nov; 40(5):776-81. PubMed ID: 8957019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for proteasome involvement in polyglutamine disease: localization to nuclear inclusions in SCA3/MJD and suppression of polyglutamine aggregation in vitro.
    Chai Y; Koppenhafer SL; Shoesmith SJ; Perez MK; Paulson HL
    Hum Mol Genet; 1999 Apr; 8(4):673-82. PubMed ID: 10072437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered expression of carbonic anhydrase-related protein XI in neuronal cells expressing mutant ataxin-3.
    Hsieh M; Chang WH; Hsu CF; Nishimori I; Kuo CL; Minakuchi T
    Cerebellum; 2013 Jun; 12(3):338-49. PubMed ID: 23184527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Silencing mutant ataxin-3 rescues motor deficits and neuropathology in Machado-Joseph disease transgenic mice.
    Nóbrega C; Nascimento-Ferreira I; Onofre I; Albuquerque D; Hirai H; Déglon N; de Almeida LP
    PLoS One; 2013; 8(1):e52396. PubMed ID: 23349684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of the autophagic beclin-1 protein clears mutant ataxin-3 and alleviates Machado-Joseph disease.
    Nascimento-Ferreira I; Santos-Ferreira T; Sousa-Ferreira L; Auregan G; Onofre I; Alves S; Dufour N; Colomer Gould VF; Koeppen A; Déglon N; Pereira de Almeida L
    Brain; 2011 May; 134(Pt 5):1400-15. PubMed ID: 21478185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ataxin-3 is translocated into the nucleus for the formation of intranuclear inclusions in normal and Machado-Joseph disease brains.
    Fujigasaki H; Uchihara T; Koyano S; Iwabuchi K; Yagishita S; Makifuchi T; Nakamura A; Ishida K; Toru S; Hirai S; Ishikawa K; Tanabe T; Mizusawa H
    Exp Neurol; 2000 Oct; 165(2):248-56. PubMed ID: 10993685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Silencing ataxin-3 mitigates degeneration in a rat model of Machado-Joseph disease: no role for wild-type ataxin-3?
    Alves S; Nascimento-Ferreira I; Dufour N; Hassig R; Auregan G; Nóbrega C; Brouillet E; Hantraye P; Pedroso de Lima MC; Déglon N; de Almeida LP
    Hum Mol Genet; 2010 Jun; 19(12):2380-94. PubMed ID: 20308049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brainstem in Machado-Joseph disease: atrophy or small size?
    Horimoto Y; Matsumoto M; Yuasa H; Kojima A; Nokura K; Katada E; Yamamoto T; Yamamoto H; Mitake S
    Eur J Neurol; 2008 Jan; 15(1):102-5. PubMed ID: 18042234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conserved domains and lack of evidence for polyglutamine length polymorphism in the chicken homolog of the Machado-Joseph disease gene product ataxin-3.
    Linhartová I; Repitz M; Dráber P; Nemec M; Wiche G; Propst F
    Biochim Biophys Acta; 1999 Feb; 1444(2):299-305. PubMed ID: 10023088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell cycle arrest enhances the in vitro cellular toxicity of the truncated Machado-Joseph disease gene product with an expanded polyglutamine stretch.
    Yoshizawa T; Yamagishi Y; Koseki N; Goto J; Yoshida H; Shibasaki F; Shoji S; Kanazawa I
    Hum Mol Genet; 2000 Jan; 9(1):69-78. PubMed ID: 10587580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the rat spinocerebellar ataxia type 3 gene.
    Schmitt I; Brattig T; Gossen M; Riess O
    Neurogenetics; 1997 Sep; 1(2):103-12. PubMed ID: 10732811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.